Press release
Global Vulvar Cancer Market Insights: Emerging Challenges, Limited Treatment Options, and Advances in Targeted Therapies Shaping Industry Growth
The Global Vulvar Cancer Market is projected to reach USD 861.8 million by 2031, growing at a CAGR of 5.9% during 2024-2031. Vulvar cancer, though one of the rarer gynecological cancers, represents an area with significant unmet medical needs. The market is defined by a limited range of treatment options and a relatively small patient population, creating opportunities for innovation and targeted therapeutic advancements.Vulvar Cancer Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/vulvar-cancer-market?un
The Vulvar Cancer Market refers to the global healthcare sector dedicated to the diagnosis, treatment, and management of vulvar cancer, a rare type of gynecologic malignancy that affects the external female genitalia.
Industry News of USA and Japan:
USA
➤ Clinical Advances: At the 2025 American Society of Clinical Oncology (ASCO) meeting, a Phase 2 trial demonstrated that combining pembrolizumab with cisplatin and radiotherapy, followed by maintenance pembrolizumab, significantly improved the objective response rate in patients with unresectable vulvar cancer. A follow-up report confirmed that this regimen was both safe and effective.
➤ Treatment Guidelines & Therapeutic Options: Pembrolizumab remains approved "tissue-agnostically" by the FDA for tumors with PD-L1 positivity, high tumor mutational burden (TMB-high), or MSI-high/dMMR status. The National Comprehensive Cancer Network (NCCN) endorses pembrolizumab as a second-line option for advanced or metastatic vulvar squamous cell carcinoma meeting these biomarker criteria.
Japan
➤ Regulatory & Approval News: While no vulvar cancer drug approvals have occurred recently, Daiichi Sankyo's April 2025 financial report mentions achievements in FY2024, including filing for a vulvar cancer indication expected approval is targeted for Japan FY2025 H1.
➤ Insights from Research: A recent genomic profiling study highlighted that the incidence of vulvar carcinoma in Japan stands at 0.2-0.4 per 100,000 women per year, considerably lower compared to around 2.5 per 100,000 in the USA.
Key Players:
• Pfizer Inc.,
• ISA Pharmaceuticals,
• Ono Pharmaceutical Co., Ltd.,
• AstraZeneca,
• Celgene Corporation,
• Bristol-Myers Squibb Company,
• Sanofi,
• PDS Biotechnology Corporation,
• Novartis AG,
• Merck & Co.
Growth Forecast Projected:
The Global Vulvar Cancer Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Research Process:
Both primary and secondary data sources have been used in the global Vulvar Cancer Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=vulvar-cancer-market
Market Segmentation:
➤ By Cancer Type: Vulvar Squamous Cell Carcinoma, Adenocarcinoma, Basal Cell Carcinoma, Sarcoma, Vulvar Melanoma, Others
➤ By Treatment: Type: Chemotherapy, Surgery, Radiation therapy, Others
➤ By End-User: Hospitals, Clinics, Cancer Research Institutes, Others
Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
Benefits of the Report:
➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Top-down and bottom-up approach for regional analysis
➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.
➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market
Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/digital-diabetes-market
People Also Ask:
➠ What is the global sales, production, consumption, import, and export value of the Vulvar Cancer Market?
➠ Who are the leading manufacturers in the global Digital Diabetes industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?
➠ What opportunities and challenges do vendors in the global Digital Diabetes industry face?
➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?
➠ What are the key factors and limitations affecting the growth of the Vulvar Cancer Market?
➠ What are the various sales, marketing, and distribution channels in the global industry?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Vulvar Cancer Market Insights: Emerging Challenges, Limited Treatment Options, and Advances in Targeted Therapies Shaping Industry Growth here
News-ID: 4147520 • Views: …
More Releases from DataM intelligence 4 Market Research LLP

United States Rainscreen Cladding Market 2025 | Growth Drivers, Key Players & In …
Market Size and Growth
The Global Rainscreen Cladding Market is expected to grow at a high CAGR of 7.5% during the forecast period (2024-2031).
Key Development:
United States: Recent Industry Developments
✅ In August 2025, StoVentec launched a new rainscreen system featuring high-density noncombustible cladding with continuous insulation and a weather-tight air- and water-resistive barrier. Panels are available up to 4' × 10' and can be customized into various shapes and sizes.
✅ In July…

"United States Mining Equipment Market Size, Share, Trends, and Growth Forecast …
The Global Mining Equipment Market reached US$ 24.5 billion in 2023 and is expected to reach US$ 34.0 billion by 2031, growing with a CAGR of 4.2% during the forecast period 2024-2031.
Download Exclusive Sample Report: https://www.datamintelligence.com/download-sample/mining-equipment-market?OPjk
Key Development:
United States: Recent Industry Developments
✅ In the United States, mining equipment manufacturers are accelerating investments in automation and sustainable technologies. OEMs are rolling out next-generation electric haul trucks and battery-powered excavators designed…

United States Distributed Power Generation Market Size, Share, Analysis | Exclus …
"Distributed Power Generation Market is expected to grow at a high CAGR during the forecast period (2024-2031)." As per DataM intelligence research report
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/distributed-power-generation-market?sb
United States: Recent Industry Developments
✅ In October 2025, Tesla Energy launched its Solar + Powerwall distributed generation solution for residential and commercial clients, backed by a $25 million investment in R&D and installation infrastructure.
✅ In September 2025,…

United States Feed Phytogenics Market with CAGR of 9.8% during 2024-2031 - Exclu …
"Global Feed Phytogenics market is estimated to grow with at a CAGR of 9.8 % during the forecast period from 2024-2031" As per DataM intelligence research report
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/feed-phytogenics-market?sb
United States: Recent Industry Developments
✅ In October 2025, Cargill launched a new line of feed phytogenics for poultry and swine, incorporating plant-derived bioactive compounds to improve gut health and feed efficiency. The launch…
More Releases for Vulvar
Vulvar Cancer Market is expected to nearly double by 2034, reaching USD 850 mill …
Vulvar cancer is a rare gynecologic malignancy that arises on the external female genitalia, most commonly as squamous cell carcinoma, though melanoma, adenocarcinoma, and sarcoma subtypes also occur. While it accounts for only 4-5% of all gynecologic cancers, vulvar cancer is associated with significant morbidity, especially when diagnosed late. Risk factors include human papillomavirus (HPV) infection, lichen sclerosus, smoking, and advancing age.
Download Full PDF Sample Copy of Market Report @…
Global Vulvar and Vaginal Atrophy Therapy Market Imapct of AI and Automation
Vulvar and Vaginal Atrophy Therapy Market Impact of AI and Automation
The Vulvar and Vaginal Atrophy (VVA) therapy market experienced a substantial valuation in 2022, with the market size reaching approximately USD 1.2 billion. This growth reflects a compound annual growth rate (CAGR) of around 6.8% from 2021 to 2022. The demand for VVA therapies has been driven by an increasing prevalence of postmenopausal women and the rising awareness of available…
Vulvar Cancer Market 2024 Size, Global Report till 2031 | Pfizer Inc., ISA Pharm …
A new Report by DataM Intelligence, titled " Vulvar Cancer Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031," offers a comprehensive analysis of the industry, which comprises insights on the Vulvar Cancer market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
This report has a complete table of contents, figures, tables, and charts, as well as insightful analysis. The Vulvar Cancer market…
Global Vulvar Cancer Market Competitive landscape, Company profile By 2016- 2023
Market Highlights
Global vulvar cancer market at a CAGR of 5.8% during forecasted period 2017-2023
Vulvar cancer is squamous cell skin cancer that occurs in elderly women. It is one of the rare type of cancer and the 4th common gynecologic cancer. Human papillomavirus infection, vulvar intraepithelial neoplasia, heavy cigarette smoking and many other things are major risk factors for this diseases. Beside these women suffering from HIV are also prone to…
Vulvar Cancer Market Research in-Depth Analysis, Worldwide Forecast 2027
Market Research Future published a Half-Cooked Research Report on Global Vulvar Cancer Information, by types, by type of treatment, by end users, Forecast 2027
Intended Audience
• Vulvar Cancer drug manufacturers
• Vulvar Cancer drug Suppliers
• Pharmaceutical companies
• Research and Development (R&D) Companies
• Medical Research Laboratories
• Academic Medical Institutes and Universities
Market Scenario:
Vulvar cancer is an uncommon disease in which cancer cells structure in the tissues of the vulva having vulvar intraepithelial neoplasia or HPV contamination which can influence the…
Vulvar Cancer Market : Evolving Technology, Trends And Industry Analysis – 202 …
Global Vulvar Cancer Information, by types (squamous cell carcinomas, vulvar intraepithelial neoplasia (VIN), human papillomavirus (HPV) by type of treatment (Removal of lymph nodes, radiation therapy, chemotherapy, Neoadjuvant chemoradiation, drugs) by end users (hospitals, cancer research centers, clinics) - Forecast to 2027
Market Synopsis of Vulvar Cancer Market:
Market Scenario:
Vulvar cancer is an uncommon disease in which cancer cells structure in the tissues of the vulva having vulvar intraepithelial neoplasia…